AAAAAA

   
Results: 1-10 |
Results: 10
Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation
Authors: Henderson, K Eisman, J Keogh, A MacDonald, P Glanville, A Spratt, P Sambrook, P
Citation: K. Henderson et al., Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation, J BONE MIN, 16(3), 2001, pp. 565-571
Pulmonary vascular resistance and reactivity in children with end-stage cardiomyopathy
Authors: Hughes, ML Kleinert, S Keogh, A Macdonald, P Wilkinson, JL Weintraub, RG
Citation: Ml. Hughes et al., Pulmonary vascular resistance and reactivity in children with end-stage cardiomyopathy, J HEART LUN, 19(7), 2000, pp. 701-704
Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation
Authors: Keogh, A Macdonald, P Kaan, A Aboyoun, C Spratt, P Mundy, J
Citation: A. Keogh et al., Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation, J HEART LUN, 19(6), 2000, pp. 529-537
Effect of calcitriol on bone loss after cardiac or lung transplantation
Authors: Sambrook, P Henderson, NK Keogh, A Macdonald, P Glanville, A Spratt, P Bergin, P Ebeling, P Eisman, J
Citation: P. Sambrook et al., Effect of calcitriol on bone loss after cardiac or lung transplantation, J BONE MIN, 15(9), 2000, pp. 1818-1824
Author's response to the letter 'Predicting the occurrence of diabetes mellitus in recipients of heart transplants'
Authors: Depczynski, B Daly, B Campbell, LV Chisholm, DJ Keogh, A
Citation: B. Depczynski et al., Author's response to the letter 'Predicting the occurrence of diabetes mellitus in recipients of heart transplants', DIABET MED, 17(8), 2000, pp. 624-624
Predicting the occurrence of diabetes mellitus in recipients of heart transplants
Authors: Depczynski, B Daly, B Campbell, LV Chisholm, DJ Keogh, A
Citation: B. Depczynski et al., Predicting the occurrence of diabetes mellitus in recipients of heart transplants, DIABET MED, 17(1), 2000, pp. 15-19
Determination of P2X(1)alpha-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles
Authors: Berry, DA Balcar, VJ Barden, JA Keogh, A dos Remedios, CG
Citation: Da. Berry et al., Determination of P2X(1)alpha-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles, ELECTROPHOR, 21(17), 2000, pp. 3857-3862
Increase in expression of P-2X1 receptors in the atria of patients suffering from dilated cardiomyopathy
Authors: Berry, DA Barden, JA Balcar, VJ Keogh, A dos Remedios, CG
Citation: Da. Berry et al., Increase in expression of P-2X1 receptors in the atria of patients suffering from dilated cardiomyopathy, ELECTROPHOR, 20(10), 1999, pp. 2059-2064
Cyclosporine plasma unbound fraction in heart and lung transplantation recipients
Authors: Akhlaghi, F Ashley, J Keogh, A Brown, K
Citation: F. Akhlaghi et al., Cyclosporine plasma unbound fraction in heart and lung transplantation recipients, THER DRUG M, 21(1), 1999, pp. 8-16
Idoxifene derivatives are less reactive to DNA than tamoxifen derivatives,both chemically and in human and rat liver cells
Authors: Osborne, MR Hewer, A Davis, W Strain, AJ Keogh, A Hardcastle, IR Phillips, DH
Citation: Mr. Osborne et al., Idoxifene derivatives are less reactive to DNA than tamoxifen derivatives,both chemically and in human and rat liver cells, CARCINOGENE, 20(2), 1999, pp. 293-297
Risultati: 1-10 |